openPR Logo
Press release

Necrotising Enterocolitis Market Application, Opportunity And Forecast To 2023 – Abbott Laboratories Inc. (U.S.), Astellas Pharma Inc. (Japan), Bayer HealthCare AG (Germany) and Becton

06-01-2018 05:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Necrotising Enterocolitis Market Application, Opportunity

Market Scenario

The global Necrotising Enterocolitis (NEC) market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023.

Necrotizing enterocolitis is the most common cause of gastrointestinal-related morbidity and mortality. The most premature infants are the most vulnerable. According to a study published in the Advances in Neonatal Care (2013), it was estimated that approximately 12% of infants born with the body weight of less than 1500 g are likely to develop Necrotizing Enterocolitis. The ascites condition is also found to be associated with Stage IIa and IIIa. The severity of the condition pushes the demand for better diagnosis and treatment approaches.  

Reqeust for Reports Sample @ https://www.marketresearchfuture.com/sample_request/5999

Notably, the market is expected to expand in the near future due to the prevalence of necrotizing enterocolitis.

Various other factors such as improved reimbursement policies in developed countries, improving regulatory framework, growing research funding, unmet medical needs, and increasing government assistance are continuously contributing to the growth of the global Necrotising Enterocolitis (NEC) market. The increasing contribution of marketers is also fueling the growth of the market. For instance, on February 15, 2018, Prometic Life Sciences Inc. received the FDA orphan drug designation status to its Inter-Alpha-Inhibitor-Proteins ("IaIp") for the treatment of necrotizing enterocolitis.

Despite these drivers, there are some issues associated with the Necrotising Enterocolitis (NEC) market. The complications associated with the treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

Intended Audience

Pharmaceutical Companies
Medical Devices Companies
Research and Development (R&D) Companies
Government Research Institutes
Academic Institutes and Universities
Regional Market Summary

The Americas dominates the Necrotising Enterocolitis (NEC) market owing to the increasing prevalence of chronic pain, well-developed technology, high healthcare expenditure, and the presence of leading players. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the U.S. region was reported to be USD 3.2 trillion hospital care accounted for a share of 32.3%.

Europe holds the second position in the Necrotising Enterocolitis (NEC) market. It is expected that the increasing contribution towards research and development and increasing competition among marketers are likely to drive the European Necrotising Enterocolitis (NEC) market.

Asia Pacific is the fastest growing Necrotising Enterocolitis (NEC) market owing to a huge patient pool, increasing demand for treatment, and rising healthcare expenditure. As per the data suggested by the Australian Institute of Health and Welfare during 2015 to 2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014 to 2015.

The Middle East and Africa holds the lowest share of the global Necrotising Enterocolitis (NEC) market due to low development, lack of technical knowledge, and poor medical facilities.

Request Full Report @ https://www.marketresearchfuture.com/reports/necrotising-enterocolitis-market-5999

Key Players

Some of the key players in the global Necrotising Enterocolitis (NEC) market are Abbott Laboratories Inc. (U.S.), Astellas Pharma Inc. (Japan), Bayer HealthCare AG (Germany), Becton, Dickinson and Company (BD) (U.S.), Bristol-Myers Squibb Company (U.S.), Daiichi Sankyo Company , Ltd. (Japan), Eli Lilly and Co. (U.S.), Enzon Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GI Supply (U.S.), GlaxoSmithKline Plc (UK), Kyorin Pharmaceutical Co., Ltd. (U.S.), Medtronic Plc (U.S.), Merck & Co. Inc. (U.S.), MiddleBrook Pharmaceuticals (Japan), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Sanofi-Aventis (France), Sequana Medical AG (Switzerland), Takeda Pharmaceutical Company, Ltd. (Japan), and others.

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Necrotising Enterocolitis Market Application, Opportunity And Forecast To 2023 – Abbott Laboratories Inc. (U.S.), Astellas Pharma Inc. (Japan), Bayer HealthCare AG (Germany) and Becton here

News-ID: 1068864 • Views: 967

More Releases from Market Research Future

Feed Acidulants Market: Top Suppliers, Business Development Market and Forecast …
Feed Acidulants Market-Overview The escalation in animal feed demand due to increased livestock rearing is estimated to boost the feed acidulants market. The agriculture reports are made by Market Research Future, which includes market choices for advance. A promising CAGR is estimated to promote the global market in the coming period. The raised intake of animal-based products is predicted to add momentum to the feed acidulants industry share in the forthcoming period.
Consumption of Organically Grown Crops to Benefit Global Biorational Pesticides …
Biorational pesticides are materials which causes minimal to zero harm to humans, animals, and the surrounding environment. These pesticides can contain organisms or formulations derived from biological entities. The global biorational pesticides market report by Market Research Future (MRFR) contains insights on growth enablers, opportunities, restraints, and challenges to be faced by the industry for the period of 2018 to 2023 (forecast period). The outbreak of the COVID-19 virus and
Bicycle Apparels and Accessories Market To Benefit From Healthy Lifestyle Adopti …
Bicycle Apparels & Accessories Market-Overview Increased engagement in outdoor activities and increased knowledge of the benefits of these activities on a child's health have driven the global cycling apparels and accessories market in recent years. According to Market Research Future, the market will gain a CAGR of 5.05% and reach a value of USD 9,529.1 million by 2027. The global bicycle apparels and accessories market grew due to increased participation in outdoor
Are Wireless Phone Chargers the Perfect Alternatives to their Wired Counterparts …
Introduction to Wireless Phone Charging Wireless phone charging is currently all the rage worldwide, given its ability to deliver energy from a single power source to the phone without requiring wires or any connections. The charging station gives out energy, on the other hand, a receiver (in this case, the phone) takes in the energy to charge the battery. To charge phones, wireless charging is one of the most convenient, safe

All 5 Releases


More Releases for Enterocolitis

Necrotising Enterocolitis Market Worldwide Healthy Growth Rate with Topmost Play …
Market Research Future has Published Prime Research Report on the Global Necrotising Enterocolitis (NEC) Market. Segmented on the Basis of Stage, Diagnosis, Treatment, and End-User. Market Scenario for Necrotising Enterocolitis Market: The Global Necrotising Enterocolitis (NEC) Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023. Necrotizing enterocolitis
Necrotising Enterocolitis Market Worldwide Healthy Growth Rate with Topmost Play …
Market Research Future has Published Prime Research Report on the Global Necrotising Enterocolitis (NEC) Market. Segmented on the Basis of Stage, Diagnosis, Treatment, and End-User. Market Scenario for Necrotising Enterocolitis Market: The Global Necrotising Enterocolitis (NEC) Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023. Necrotizing enterocolitis
Enterocolitis Market Demand, Overview, Price and Forecasts To 2022
ReportBazzar has released its latest research-based report entitled ‘Enterocolitis’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Enterocolitis market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Enterocolitis market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact
Enterocolitis Market Pit Falls, Present Scenario and Growth Prospects from 2017 …
ReportBazzar has released its latest research-based report entitled ‘Enterocolitis’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Enterocolitis market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Enterocolitis market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact
Enterocolitis - Pipeline Review, H1 2017 - Pharmaceuticals Market Report
Enterocolitis is an inflammation of the large and small intestines. Symptoms include fever, abdominal swelling, nausea, diarrhea, rectal bleeding and sluggishness. Causes of enterocolitis include Inflammation of the intestinal tissues, delayed gastric emptying, abdominal wall erythema, apnea, sepsis and cardiovascular collapse. Treatment includes antibiotics. Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068452 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Enterocolitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics
Global Enterocolitis Market Growth Trends, Key Players, Competitive Strategies a …
The report provides comprehensive information on the therapeutics under development for Enterocolitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Enterocolitis